CanniMed Therapeutics (TSE:CMED) Trading Down 5.3%

CanniMed Therapeutics Inc. (TSE:CMED – Get Rating) fell 5.3% during mid-day trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares were traded during trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.

The stock’s 50 day moving average price is C$27.00.

CanniMed Therapeutics Company Profile (TSE:CMED)

CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.

Further Reading

• Ride Out The Recession With These Dividend Kings 
• MarketBeat: Week in Review 6/13 – 6/17
• eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
• Honda’s Stock Continues To Fly Under The Radar
• Vuzix Stock Stays Optimistic

Want More Great Investing Ideas?